|
SPG21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.523740E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.445600E-04 |
| Normal-vs-Stage2 |
3.302600E-03 |
| Normal-vs-Stage3 |
3.850000E-01 |
| Normal-vs-Stage4 |
6.093900E-02 |
| Stage1-vs-Stage2 |
7.527600E-01 |
| Stage1-vs-Stage3 |
1.827430E-01 |
| Stage1-vs-Stage4 |
8.064000E-01 |
| Stage2-vs-Stage3 |
1.942550E-01 |
| Stage2-vs-Stage4 |
5.689400E-01 |
| Stage3-vs-Stage4 |
4.870600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.611100E-04 |
| Normal-vs-AfricanAmerican |
9.957800E-02 |
| Normal-vs-Asian |
7.225200E-01 |
| Caucasian-vs-AfricanAmerican |
1.335610E-01 |
| Caucasian-vs-Asian |
3.523400E-01 |
| AfricanAmerican-vs-Asian |
4.936000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.760400E-04 |
| Normal-vs-Female |
2.369400E-01 |
| Male-vs-Female |
1.752080E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.409700E-02 |
| Normal-vs-Extreme_Weight |
5.364100E-04 |
| Normal-vs-Obese |
1.174140E-02 |
| Normal-vs-Extreme_Obese |
2.499900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.145000E-01 |
| Normal_Weight-vs-Obese |
6.154000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.429800E-01 |
| Extreme_Weight-vs-Obese |
4.304000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.868000E-01 |
| Obese-vs-Extreme_Obese |
6.008000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.735200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.272100E-02 |
| Normal-vs-Age(61-80Yrs) |
8.248800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.876200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.481200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.338200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.152400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.591640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.012200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.541200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.344500E-03 |
| Normal-VS-Type2 PRCC |
3.365900E-02 |
| Normal-VS-KIRP CIMP |
3.81940000000469E-05 |
| Normal-VS-Unclassified PRCC |
2.678500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.772600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.651500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.998600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.818500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.502200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.937900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.374260E-02 |
| Normal-vs-N1 |
7.260200E-01 |
| Normal-vs-N2 |
1.312340E-02 |
| N0-vs-N1 |
2.193800E-01 |
| N0-vs-N2 |
4.497800E-01 |
| N1-vs-N2 |
2.963400E-01 |
|
|
